Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Pharmaceuticals & Biotechnology | Small Cap
Health Score : 3.45Ortin Global Ltd, operating within the Healthcare Services sector, shows a mixed financial performance. Averages, indicating a need for strategic improvements across various financial aspects. The company demonstrates potential in managing its debt and sales-related efficiency, but struggles with liquidity, growth, coverage, and profitability. While capital expenditure management is a notable strength, earnings and overall profit margins need attention. The company's ability to meet its short-term obligations is questionable, but its debt management is strong. Future success hinges on improving core profitability and liquidity to ensure long-term sustainability and competitiveness.
Health Score : 3.45Ortin Global Ltd, operating within the Healthcare Services sector, shows a mixed financial performance. Averages, indicating a need for strategic improvements across various financial aspects. The company demonstrates potential in managing its debt and sales-related efficiency, but struggles with liquidity, growth, coverage, and profitability. While capital expenditure management is a notable strength, earnings and overall profit margins need attention. The company's ability to meet its short-term obligations is questionable, but its debt management is strong. Future success hinges on improving core profitability and liquidity to ensure long-term sustainability and competitiveness.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
-17.43
Industry Median
30.91
Small Cap Median
28.64
P/E RATIO
-17.43
P/B RATIO
10.43
Industry Median
3.69
Small Cap Median
3.11
P/S RATIO
30.56
Industry Median
3.74
Small Cap Median
3.02
Others
PEG RATIO
0.00
EV/EBITDA RATIO
-17.96
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹15.86 as on Sep 1, 2026.
Growth Score : 2.00The company's growth ratios suggest significant challenges. A across all metrics indicates potential stagnation or contraction. Without revenue, profit, or asset growth, the company may struggle to remain competitive. Strategic initiatives are needed to stimulate growth and capitalize on market opportunities.
Revenue Growth RatePoorOperating Profit Growth RatePoorEarnings Per Share (EPS) GrowthPoorAsset Growth RatePoorNet Income Growth RatePoor| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 0.86 | -27.1 | -66.5 | -83.08 | 20.59 |
| Operating Profit Growth Rate | -69.35 | 39.47 | -928.3 | 79.73 | 19.1 |
| Earnings Per Share (EPS) Growth | -141.88 | 77.55 | -8890.91 | 89.38 | 13.33 |
| Asset Growth Rate | -2.59 | 2.37 | -68.54 | -43.33 | 23.02 |
| Net Income Growth Rate | -142.11 | 77.5 | -8833.33 | 89.43 | 12.94 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Ortin Global Ltd | 3.45 | -17.43 | Neutral | -0.72 | -0.91 | -0.74 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
No Stock Reports Available at This Moment.
Ortin Global Ltd is an India-based pharmaceutical company primarily engaged in marketing a diverse portfolio of branded generic products. The company focuses on various therapeutic segments, including antibiotics, pain management, cardiology, diabetology, and oncology, serving the domestic Indian market through its distribution network.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Ortin Global Ltd's P/E ratio (TTM) is -17.43, compared to the industry median of 30.91 and large cap median of 28.64.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Ortin Global Ltd's P/B ratio is 10.43, compared to the industry median of 3.69 and large cap median of 3.11.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Ortin Global Ltd's P/S ratio is 30.56, compared to the industry median of 3.74 and large cap median of 3.02.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Ortin Global Ltd's PEG ratio is 0.64.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Ortin Global Ltd's EV/EBITDA ratio is -17.96.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Ortin Global Ltd's ROE is -59.68%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Ortin Global Ltd's ROA is -15.48%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Ortin Global Ltd's ROCE is -32.14%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Ortin Global Ltd's operating margin is -175.61%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Ortin Global Ltd's net margin is -180.49%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Ortin Global Ltd's current ratio is 1.93.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Ortin Global Ltd's debt-to-equity ratio is 0.82.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Ortin Global Ltd's interest coverage ratio is -13.75.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Ortin Global Ltd's DPS is ₹0.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Ortin Global Ltd's EPS is 13.33.
(Source line: "Ratios as of 26 Sept 2026, based on last traded price of ₹15.86. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 2012
Headquarters: Hyderabad, Telangana
Core Offerings: Branded Generics, Antibiotics, Pain and Inflammation, Cardiology, Diabetology
Stock Listing: NSE (ORTINGLOBE), BSE (539287)
Promoter: Palle Venkat Ram Reddy Group
Ortin Global Ltd was incorporated on January 23, 2012. Since its inception, the company has focused on establishing itself in the Indian pharmaceutical market by marketing a range of branded generic products across various therapeutic areas. It has steadily expanded its product portfolio and distribution network within the domestic market.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Pharmaceutical Products (Branded Generics) | 100% | Operating Profit |
Branded Generics: Focuses on marketing a comprehensive range of branded generic pharmaceutical products across key therapeutic segments in India.
Therapeutic Areas: Key offerings include medicines for Antibiotics, Pain and Inflammation, Cardiology, Diabetology, Gastroenterology, Dermatology, Oncology, and nutritional supplements.
Mr. Palle Venkat Ram Reddy serves as the Chairman & Managing Director. He is a key promoter and steers the strategic direction and operational management of the company.
No major subsidiaries reported.
No major recent corporate actions on record.
The Ortin Global Ltd share price today is ₹15.86 on NSE (ORTINGLOBE), as of 26 Sept 2026.
As of 26 Sept 2026, Ortin Global Ltd share price is ₹15.86, with previous close ₹15.86. Today's range is ₹15.86 to ₹15.86. The 52-week range is ₹11.51 to ₹21.30.
As of today, Ortin Global Ltd's market cap is ₹12.53 crore (Small Cap).
Ortin Global Ltd's current P/E ratio is -17.43, compared to the PHARMACEUTICALS & BIOTECHNOLOGY sector average of 32.
Ortin Global Ltd's current P/B ratio is 10.43.
Ortin Global Ltd's current dividend yield is N/A. Last dividend of ₹0.00 per share was declared on N/A.
Ortin Global Ltd's EPS (TTM) is ₹13.33.
Ortin Global Ltd is an India-based pharmaceutical company primarily engaged in marketing a diverse portfolio of branded generic products. The company focuses on various therapeutic segments, including antibiotics, pain management, cardiology, diabetology, and oncology, serving the domestic Indian market through its distribution network.
Ortin Global Ltd is promoted by Palle Venkat Ram Reddy Group, holding 1.23% as of 26 Sept 2026.
Ortin Global Ltd is listed on NSE (ORTINGLOBE) and BSE (539287). Its next quarterly results are expected on August 2024.
Shareholding & Ownership Structure
